FDA.reportPublic FDA data

Rykindo 50 MG Extended Release Injection

RxCUI
2639738
RxNorm name
Rykindo 50 MG Extended Release Injection
Display name
Rykindo 50 MG Extended Release Injection
Full name
Rykindo 50 MG Extended Release Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:59

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Rykindo extended-release microspheresRISPERIDONEShandong Luye Pharmaceutical Co., Ltd.58534c96-96f5-4c2e-a061-92d4506aee912026-05-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2639738

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
58534c96-96f5-4c2e-a061-92d4506aee91Rykindo 50 MG Extended Release Injection [PSN] · risperidone 50 MG Injection [Rykindo] [SBD] · Rykindo 50 MG Injection [SY]310These highlights do not include all the information needed to use RYKINDO ® safely and effectively. See full prescribing information for RYKINDO ® . RYKINDO ® (risperidone) for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 199320260526